Literature DB >> 29780724

Uniportal VATS lobectomies-masterclass in Bratislava.

Miroslav Janik1, Peter Juhos1.   

Abstract

On February 5-6, an event on uniportal VATS approach to pulmonary resections took place in Bratislava. It focused on developing uniportal VATS technique. The two-day event gave opportunity to discuss the topic with masters of thoracic surgery such as Prof. Hasan Batirel and Diego Gonzalez, to train basic skills on simulators developed by Dr. Tomaz Stupnik and to watch live surgery performed by Diego Gonzalez. Two patients underwent uniportal VATS lobectomy. This event was another step to advance miniinvasive major pulmonary procedures.

Entities:  

Keywords:  Uniportal video-assisted thoracoscopic lobectomy

Year:  2018        PMID: 29780724      PMCID: PMC5945785          DOI: 10.21037/jovs.2018.04.08

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  5 in total

1.  Uniportal VATS-a new era in lung cancer surgery.

Authors:  Calvin S H Ng; Diego Gonzalez-Rivas; Thomas A D'Amico; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Uniportal video-assisted thoracoscopic lobectomy: two years of experience.

Authors:  Diego Gonzalez-Rivas; Marina Paradela; Ricardo Fernandez; Maria Delgado; Eva Fieira; Lucía Mendez; Carlos Velasco; Mercedes de la Torre
Journal:  Ann Thorac Surg       Date:  2012-12-05       Impact factor: 4.330

Review 3.  Uniportal VATS: the first German experience.

Authors:  Mahmoud Ismail; Melanie Helmig; Marc Swierzy; Jens Neudecker; Harun Badakhshi; Diego Gonzalez-Rivas; Jens C Rückert
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

4.  From open surgery to uniportal VATS: asturias experience.

Authors:  Javier Aragón; Itzell Pérez Méndez
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?

Authors:  Matthew G Hartwig; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.